MSLP - MusclePharm Corporation

Other OTC - Other OTC Delayed Price. Currency in USD

MusclePharm Corporation

Building A
4721 Ironton Street
Denver, CO 80239
United States

SectorConsumer Cyclical
IndustryPersonal Services
Full Time Employees56

Key Executives

NameTitlePayExercisedYear Born
Mr. Ryan Charles DrexlerExec. Chairman, CEO & Pres1.29MN/A1971
Mr. Brian CasuttoExec. VP of Sales and Operations & Director657.76kN/A1971
John Mills MillsSr. Managing DirectorN/AN/AN/A
Dr. Roscoe M. Moore Jr., DVM, MPH, Ph.D., DScChief Scientific Director and Member of Scientific Advisory BoardN/AN/A1954
Mr. Matthew KerbelChief Marketing OfficerN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


MusclePharm Corporation develops, manufactures, markets, and distributes nutritional supplements in the United States and internationally. It offers a range of powders, capsules, tablets, and gels. The company's MusclePharm Hybrid series products include Assault, Amino1, and Combat Protein Powder; and MusclePharm Core products comprise BCAA 3:1:2, CLA Core, and Fish Oil to meet the day-in and day-out demands of athletes. It also provides FitMiss, which is designed and formulated primarily for women lifestyle to cover various needs, including weight loss, multi-vitamins, protein shakes, detox, skin care, and pre-workout energy mixes. MusclePharm Corporation sells its products to various fitness enthusiasts, such as professional, combat sport, weight training, bodybuilding, running, and various team and individual sports, as well as individuals who lead an active lifestyle. The company was founded in 2006 and is headquartered in Denver, Colorado.

Corporate Governance

MusclePharm Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.